Trials / Unknown
UnknownNCT03016364
Application Software in Dosage Adjustment for Advanced Cancer Patients With Pain
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this trial is to determine whether Application (APP) would help clinical doctors to adjust the dose of Oxycodone Hydrochloride Prolonged-release Tablets in advanced patients with cancer pain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | APP software | A software used to by physicians to adjust the dose of Oxycodone Hydrochloride Prolonged-release Tablets for advanced patient's with cancer pain |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2017-01-10
- Last updated
- 2019-01-23
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03016364. Inclusion in this directory is not an endorsement.